GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) » Definitions » Intrinsic Value: Projected FCF

Hunan Dajiaweikang Pharmaceutical Industry Co (SZSE:301126) Intrinsic Value: Projected FCF : ¥-6.17 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Dajiaweikang Pharmaceutical Industry Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-12-13), Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF is ¥-6.17. The stock price of Hunan Dajiaweikang Pharmaceutical Industry Co is ¥12.22. Therefore, Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 10 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Hunan Dajiaweikang Pharmaceutical Industry Co was 5.03. The lowest was 5.03. And the median was 5.03.

SZSE:301126's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.18
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Hunan Dajiaweikang Pharmaceutical Industry Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Dajiaweikang Pharmaceutical Industry Co Intrinsic Value: Projected FCF Chart

Hunan Dajiaweikang Pharmaceutical Industry Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.09 4.51 - -2.38

Hunan Dajiaweikang Pharmaceutical Industry Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.38 -3.98 -4.48 -6.17

Competitive Comparison of Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF

For the Pharmaceutical Retailers subindustry, Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Projected-FCF falls into.



Hunan Dajiaweikang Pharmaceutical Industry Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Hunan Dajiaweikang Pharmaceutical Industry Co's Free Cash Flow(6 year avg) = ¥-266.91.

Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-266.9112+1765.418*0.8)/183.053
=-6.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Dajiaweikang Pharmaceutical Industry Co  (SZSE:301126) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Hunan Dajiaweikang Pharmaceutical Industry Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=12.22/-6.1662691619415
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Dajiaweikang Pharmaceutical Industry Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Hunan Dajiaweikang Pharmaceutical Industry Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Dajiaweikang Pharmaceutical Industry Co Business Description

Traded in Other Exchanges
N/A
Address
No. 30 Fuling Road, Yuelu District, Hunan Province, Changsha, CHN, 410000
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is engaged in the distribution and retail of pharmaceuticals, biological products, medical equipment and other products.
Executives
Tang Juan Supervisors
Zhong Xue Song Director

Hunan Dajiaweikang Pharmaceutical Industry Co Headlines

No Headlines